MEDESIS PHARMA (EPA:ALMDP) | WebDisclosure

Basculer en Français

9477	Companies
185472	Keywords
117815	Articles
99316	Press releases

Home
Companies
MEDESIS PHARMA

REGULATED PRESS RELEASE

published on 07/15/2024 at 16:55, 1 year 4 months ago

MEDESIS PHARMA : RAPPORT ANNUEL 2023
REGULATED PRESS RELEASE

published on 07/15/2024 at 08:00, 1 year 4 months ago

MEDESIS PHARMA: 2023 FULL-YEAR BUSINESS AND EARNINGS
REGULATED PRESS RELEASE

published on 07/15/2024 at 08:00, 1 year 4 months ago

MEDESIS PHARMA : ACTIVITÉS & RÉSULTATS ANNUELS 2023
REGULATED PRESS RELEASE

published on 06/03/2024 at 18:00, 1 year 6 months ago

MEDESIS PHARMA : Obtention d’un financement pour poursuivre l'analyse des résultats de la première phase d'essais cliniques de phase 2 pour le traitement de la maladie d’Alzheimer
REGULATED PRESS RELEASE

published on 03/19/2024 at 18:01, 1 year 8 months ago

Termination of the agreement between NICE and GREEN S.A. and Medesis Pharma
REGULATED PRESS RELEASE

published on 03/19/2024 at 18:01, 1 year 8 months ago

Medesis Pharma : Résiliation du contrat avec la société NICE & GREEN S.A.
REGULATED PRESS RELEASE

published on 01/29/2024 at 18:00, 1 year 10 months ago

MEDESIS PHARMA : Phase 2 clinical trial for the treatment of Alzheimer's disease - Completion of the 1st phase of double-blind treatment, with good patient retention and acceptance of the treatment
MEDESIS PHARMA successfully completes Phase 2 clinical trial for Alzheimer's disease, announces Nanolithium scientific publication, participation in BIOMED Forum, and a new cash contribution

Medesis Pharma Phase 2 Clinical Trial Alzheimer's Disease Nanolithium BIOMED Forum
REGULATED PRESS RELEASE

published on 01/29/2024 at 18:00, 1 year 10 months ago

MEDESIS PHARMA : Étude clinique de phase 2 pour le traitement de la maladie d’Alzheimer - Finalisation de la 1ère phase de traitement en double aveugle avec une bonne rétention des patients et une bonne acceptation du traitement
MEDESIS PHARMA annonce la finalisation de la 1ère phase de traitement en double aveugle de l'étude clinique de phase 2 pour le traitement de la maladie d'Alzheimer, une publication scientifique sur le NanoLithium, sa participation au BIOMED Forum le 30 janvier 2024, ainsi que la sécurisation d'une augmentation de capital d'environ 400 k€

Medesis Pharma Nanolithium Traitement Alzheimer Étude Clinique Phase 2 Sécurisation Augmentation De Capital
REGULATED PRESS RELEASE

published on 01/12/2024 at 17:45, 1 year 10 months ago

MEDESIS PHARMA CONFIRME SON ÉLIGIBILITÉ AU DISPOSITIF PEA-PME
MEDESIS PHARMA confirme son éligibilité au dispositif PEA-PME pour l'année 2024, permettant l'intégration de ses actions dans les portefeuilles PEA PME. La société développe des candidats médicaments en s'appuyant sur sa technologie propriétaire Aonys@ pour le traitement de maladies graves

PEA-PME Medesis Pharma Biotechnologie Pharmaceutique Candidats Médicaments Aonys@
REGULATED PRESS RELEASE

published on 01/12/2024 at 17:45, 1 year 10 months ago

MEDESIS PHARMA : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S2 2023

Accesswire

Published on 12/05/2025 at 14:00, 30 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 30 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 55 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 30 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 7 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 13 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 20 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 45 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 30 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 13:58, 31 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 5 hours 45 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 5 hours 45 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 5 hours 47 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 20 hours 15 minutes ago

Résiliation d'une convention conclue entre actionnaires

View all LES ECHOS COMFI WIRE